What class of medications does Mitalax (Bisacodyl) belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Miralax (Bisacodyl) is a Stimulant Laxative

Bisacodyl (Miralax) belongs to the stimulant laxative class of medications, specifically the diphenylmethane derivatives family. 1, 2 This classification is based on its mechanism of action, which involves stimulating intestinal motility and increasing water content in the stool.

Mechanism of Action

Bisacodyl works through a dual mechanism:

  1. Prokinetic effect: Stimulates intestinal motility by acting on the colonic mucosa
  2. Secretory effect: Increases water content in the stool

Specifically, bisacodyl:

  • Must be converted to its active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM) in the gut 3
  • Acts locally in the large bowel 3
  • Stimulates sensory nerves in the proximal colon 1
  • Increases sodium and water movement into the colonic lumen 1

Classification Context

Stimulant laxatives are one of several categories of laxatives:

  • Bulk-forming laxatives: Methylcellulose, ispaghula, sterculia
  • Osmotic laxatives: Macrogols (polyethylene glycol), lactulose, magnesium salts
  • Stimulant laxatives:
    • Anthraquinones: Senna, cascara
    • Diphenylmethane derivatives: Bisacodyl, sodium picosulfate, phenolphthalein
  • Stool softeners: Docusate sodium
  • Lubricants: Liquid paraffin

Clinical Efficacy

Bisacodyl has demonstrated effectiveness in treating constipation:

  • Doubles the mean number of bowel movements per week compared to baseline 4, 5
  • Shows similar efficacy to newer agents like prucalopride and linaclotide for achieving complete spontaneous bowel movements 3
  • May be superior to other laxatives for increasing spontaneous bowel movements per week 3

Important Considerations

  • Duration of use: While effective for short-term use, evidence for long-term use beyond 4 weeks is limited 6
  • Side effects: Generally mild but common (up to 72%), including diarrhea and abdominal pain 6
  • Contraindications: Should be avoided in intestinal obstruction 1
  • Excessive use: Can cause diarrhea and hypokalemia 1

Clinical Application

Bisacodyl is typically used:

  • When osmotic laxatives provide inadequate response 1
  • At a standard dose of 5-10 mg daily 4, 5
  • As a fast-acting stimulant laxative 2

It's important to note that despite concerns about long-term use of stimulant laxatives potentially damaging intestinal muscle or neurons, there is no clinical or animal evidence supporting this theory 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral bisacodyl is effective and well-tolerated in patients with chronic constipation.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.